Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Results by Age, Disease Duration, and Baseline "Off" Time

被引：0

作者：

Isaacson, S. ^{[1
]}

Di Lorenzo, G. ^{[2
]}

Facheris, M. ^{[3
]}

Fung, V. ^{[4
,5
]}

Henriksen, T. ^{[6
]}

Ikenaka, K. ^{[7
]}

Jia, J. ^{[3
]}

Kern, D. ^{[8
]}

Kukreja, P. ^{[3
]}

Santos Garcia, D. ^{[9
]}

Spiegel, A. ^{[3
]}

Zhang, Z. ^{[3
]}

Bergmann, L. ^{[3
]}

Carroll, C. ^{[10
]}

机构：

[1] Parkinsons Dis & Movement Disorders Ctr Boca Rato, Boca Raton, FL USA

[2] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy

[3] AbbVie Inc, N Chicago, IL USA

[4] Westmead Hosp, Movement Disorders Unit, Westmead, NSW, Australia

[5] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia

[6] Bispebjerg Hosp, Movement Disorder Clin, Dept Neurol, Copenhagen, Denmark

[7] Osaka Univ, Grad Sch Med, Osaka, Japan

[8] Univ Colorado Anschutz Med Campus, Aurora, CO USA

[9] Complejo Hosp Univ A Coruna, La Coruna, Spain

[10] Univ Plymouth, Fac Hlth, Plymouth, Devon, England

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EPO-109

引用

页码：444 / 445

页数：2